Favorable pleiotropic effects of sodium glucose cotransporter 2 inhibitors: head-to-head comparisons with dipeptidyl peptidase-4 inhibitors in type 2 diabetes patients

BACKGROUND: Sodium glucose cotransporter 2 (SGLT2) inhibitors have shown greater reductions of cardiovascular event risks than dipeptidyl peptidase-4 (DPP4) inhibitors, whereby possible mechanisms may involve the better pleiotropic effects of SGLT2 inhibitors. However, no published data are currentl...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cardiovasc Diabetol
Päätekijät: Shao, Shih-Chieh, Chang, Kai-Cheng, Lin, Swu-Jane, Chien, Rong-Nan, Hung, Ming-Jui, Chan, Yuk-Ying, Kao Yang, Yea-Huei, Lai, Edward Chia-Cheng
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2020
Aiheet:
Original Investigation
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7014757/
https://ncbi.nlm.nih.gov/pubmed/32050968
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-020-0990-2
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia